Despite the divergent impacts on gene expression of depleting ARNT or BMAL1 in ccRCC patient-derived cell lines, losing either of these HIF2α partners dramatically reduces the ability of several ccRCC cell lines to form colonies in vitro and xenograft tumors in vivo. Here, EPAS1 is linked to nonpapillary renal cell carcinoma.